Lundbeck Names Interim Leader, Effective Nov. 1, 2017 By Sam | October 30, 2017 Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva. Source: BioSpace Posted in BioPharma